Blog
RSS FeedPosted by Michael Wonder on 11 Oct 2022
Swiss drugs regulator approves one of Pfizer's COVID-19 booster shots
10 October 2022 - Swiss drugs regulator Swissmedic said on Monday it had temporarily approved Pfizer's COVID-19 booster shot targeting ...
Posted by Michael Wonder on 08 Oct 2022
Health Canada authorises COVID-19 vaccine booster targeting the Omicron BA.4/BA.5 sub-variants
7 October 2022 - Today, Health Canada authorised a second bivalent COVID-19 vaccine booster. ...
Posted by Michael Wonder on 07 Oct 2022
FDA approves vaccine for use during third trimester of pregnancy to prevent whooping cough in infants younger than two months of age
7 October 2022 - Today, the US FDA approved Boostrix (Tetanus toxoid, reduced Diphtheria toxoid and acellular Pertussis vaccine, adsorbed) for ...
Posted by Michael Wonder on 07 Oct 2022
COVID-19 vaccine safety report (6 October 2022)
6 October 2022 - To 2 October 2022, the TGA has received 703 reports which have been assessed as likely to ...
Posted by Michael Wonder on 30 Sep 2022
TGA grants provisional determination to Moderna’s COVID-19 bivalent (Original plus Omicron BA.4/BA.5) booster dose vaccine
30 September 2022 - On 28 September 2022, the TGA granted a provisional determination to Moderna's bivalent COVID-19 vaccine candidate: elasomeran ...
Posted by Michael Wonder on 29 Sep 2022
TGA provisionally approves Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran) for use in children aged 6 months to less than 5 years
29 September 2022 - On 29 September 2022, the TGA provisionally approved a paediatric dose of Pfizer’s COVID-19 vaccine, Comirnaty (tozinameran), ...
Posted by Michael Wonder on 29 Sep 2022
European Medicines Agency accepts Moderna's conditional marketing authorisation filing for its Omicron BA.4/BA.5 targeting bivalent COVID-19 vaccine
28 September 2022 - Filing follows approval of Spikevax bivalent Original/Omicron BA.1 (mRNA-1273.214), a bivalent booster vaccine targeting the Omicron BA.1 ...
Posted by Michael Wonder on 27 Sep 2022
COVID-19 vaccine procurement review says rapid access to vaccines and treatments key to on-going protection of Australians
27 September 2022 - Medicines Australia welcomes the independent review of Australia’s COVID-19 vaccine and treatment procurements by Professor Jane ...
Posted by Michael Wonder on 27 Sep 2022
Halton review into vaccine and treatment procurement
27 September 2022 - Professor Jane Halton AO has handed to Government her independent review of Australia’s COVID-19 vaccine and treatment ...
Posted by Michael Wonder on 26 Sep 2022
Pfizer and BioNTech submit application to U.S. FDA for Emergency Use Authorisation of Omicron BA.4/BA.5 adapted bivalent vaccine booster in children 5 through 11 years of age
26 September 2022 - Pfizer and BioNTech today announced they have completed a submission to the US FDA requesting Emergency Use ...
Posted by Michael Wonder on 26 Sep 2022
Novavax appeals to ATAGI to change advice as vaccine uptake falls behind
25 September 2022 - Novavax was hailed as the fix to Australia’s low inoculation rate and “the vaccine for anti-vaxxers”. So ...
Posted by Michael Wonder on 26 Sep 2022
ATAGI recommend the COVID-19 vaccination for some children aged 6 months to under 5 years
26 September 2022 - Australia’s immunisation experts, the Australian Technical Advisory Group on Immunisation, recommend COVID-19 vaccination for some children aged ...
Posted by Michael Wonder on 24 Sep 2022
Moderna asks FDA to authorise omicron Covid boosters for children as young as 6 years old
23 September 2022 - The Centers for Disease Control and Prevention, in a document published Tuesday, said it expects children to ...
Posted by Michael Wonder on 23 Sep 2022
COVID-19 vaccine safety report (23 September 2022)
23 September 2022 - To 18 September 2022, the TGA has received 712 reports which have been assessed as likely to ...
Posted by Michael Wonder on 23 Sep 2022
Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine
22 September 2022 - Pfizer said on Thursday it had submitted an application to Swissmedic for authorisation of a further ...